相似文献
1
Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
Cardiology. 1973;58(3):152-61.
2
The effect of alprenolol on hemodynamics in angina pectoris.
Acta Med Scand. 1973 May;193(5):411-8. doi: 10.1111/j.0954-6820.1973.tb10602.x.
3
[Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
Ugeskr Laeger. 1973 Jul 2;135(27):1431-8.
4
Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
J Clin Pharmacol J New Drugs. 1970 Jan-Feb;10(1):37-49.
5
A comparative study of the effect of LB-46 and propranolol on central haemodynamic in cases with angina pectoris.
Indian Heart J. 1972 Jun;24:Suppl 1:180-2.
6
Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
Acta Med Scand. 1973 May;193(5):419-24. doi: 10.1111/j.0954-6820.1973.tb10603.x.
7
Effects of cedilanid-D and alprenolol in angina pectoris.
Eur J Clin Pharmacol. 1973 Aug;6(2):113-8. doi: 10.1007/BF00562437.
8
Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Ann Clin Res. 1969 May;1(1):13-21.
9
Effects of SD/1601 on tolerance to exercise in patients with angina.
G Ital Cardiol. 1975;5(1):142-8.
10
Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
Br Heart J. 1974 Dec;36(12):1194-1200. doi: 10.1136/hrt.36.12.1194.
引用本文的文献
1
Blood volume in angina pectoris.
Br Heart J. 1979 Apr;41(4):477-80. doi: 10.1136/hrt.41.4.477.
Zotero 插件